Diamonds and Dogs
6/4/14Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals is looking great today, up 25.35% to $12.56. The biotech company saw its shares soar after news that the European Medicines Agency accepted Vanda's drug marketing authorization application for their drug, Hetlioz. Hetiloz is a non-24 hour sleep-wake disorder drug for the totally blind. More than 130,000 people in Europe suffer from this disorder (95,000 in the US). Reuters is expecting the drug to achieve sales of $295 million. Vanda shares gained over $2.50 today but are still well off of their 52-week high of $19.25.
FuelCell Energy Inc. (FCEL)
FuelCell Energy is crashing and burning today, down 7.59% to $2.19. The fuel cell plant company saw its shares fall after worse than expected earnings. For the second quarter FuelCell announced a loss of $0.04 per share on revenues of $38.3 million (down 9.8% year over year). Both numbers missed analysts' estimates for a loss of $0.03 per shares on revenue of $45.2 million. Shares of the company fell $0.18 today but are still above their 52-week low of $1.10.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.